Wednesday, February 27, 2019 11:41:06 AM
Diplomat Pharmacy (NYSE:DPLO) has postponed the release of its Q4 and FY 2018 financial results to March 15.
The Company expects to file its Form 10-K soon afterwards.
The reason for delay is that Diplomat needs to record a non-cash impairment charge related to its PBM business.
The company expects to provide an updated 2019 outlook when it reports Q4 results.
Shares are down 19% premarket.
full story: https://seekingalpha.com/news/3436168-diplomat-minus-19-percent-delaying-10-k-filing
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • Oct 1, 2024 7:00 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM